Atypical fibroxanthoma. A study with antibody to S-100 protein

Arch Dermatol. 1985 Jun;121(6):753-5. doi: 10.1001/archderm.121.6.753.

Abstract

Fourteen biopsy specimens from ten patients with atypical fibroxanthoma were studied with the peroxidase-antiperoxidase method for binding of S-100 antibody. Six specimens from four patients were minimally positive. The S-100-positive cells were observed in greatest concentrations at the periphery of the lesions and were associated with perivascular inflammatory cells. By this method, it appears that there is not a Langerhans' cell type of atypical fibroxanthoma. The S-100 antibody can help differentiate desmoplastic juvenile melanoma and malignant melanoma from atypical fibroxanthoma.

MeSH terms

  • Antibodies, Monoclonal
  • Diagnosis, Differential
  • Fibroma / analysis
  • Fibroma / pathology*
  • Histocytochemistry
  • Humans
  • Immunoenzyme Techniques
  • Melanoma / pathology
  • S100 Proteins / analysis*
  • Skin Neoplasms / analysis
  • Skin Neoplasms / pathology*

Substances

  • Antibodies, Monoclonal
  • S100 Proteins